Marie-Kathrin Breyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marie-Kathrin Breyer has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Ahmad Karimi
Ludwig Boltzmann Institute for Lung Health, Vienna, Austria
2 shared publications- Mohammad Azizzadeh
Ludwig Boltzmann Institute for Lung Health, Vienna, Austria
2 shared publications Robab Breyer-Kohansal
Ludwig Boltzmann Institute for Lung Health, Vienna, Austria
2 shared publicationsSylvia Hartl
Ludwig Boltzmann Institute for Lung Health, Vienna, Austria
2 shared publicationsBart Spaetgens
Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands
1 shared publicationBernhard Hametner
AIT Austrian Institute of Technology, Vienna, Austria
1 shared publication
Latest Publications
- Open Access
- 6 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Integration of lung function in allostatic load scoring and its impact on mortality prediction
Allostatic load refers to the physiological "wear and tear" that results from adaptation to stressors over the lifespan. In this study, we integrated lung function (LF) parameters into the calculation of the allostatic load score (ALS) to evaluate changes in its performance for predicting all-cause mortality. Data from 8,775 participants (aged 25–82 years; 52% female) who participated in the first wave of the Austrian LEAD cohort were used. “ALS without LF” was calculated using 12 parameters, including cardiovascular, metabolic, body composition, and bone mineral density measures. Z-scores of forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were integrated with the aforementioned parameters for the calculation of “ALS with LF”. Participants scored 1 point for each at-risk marker and 1 point for medication use for hypertension, diabetes, and dyslipidaemia. The total points constituted the ALS. Participants were followed-up for death for an average of 7.7 years. The association of ALS, with and without LF, with mortality was investigated using Cox proportional hazards models. ALS increased with age and was higher in males compared to females across all age categories. ALS (as a continuous variable) with LF [hazard ratio (HR): 1.19 (95% confidence interval (CI) 1.14–1.24)] and without LF [HR: 1.16 (95% CI 1.11–1.21)] showed a significant association with mortality in sex- and age-adjusted models. The adjusted models incorporating ALS as a categorical variable showed that individuals with high ALS, with [HR: 2.44 (95% CI 1.41–4.20)] and without [HR: 2.47 (95% CI 1.46–4.80)] LF parameters, had a higher risk of mortality compared to those in the low ALS group. Cox models incorporating “ALS with LF” parameters exhibited higher concordance index and R2 values, along with a lower Akaike’s information criterion indicating superior predictive power compared to models that included “ALS without LF”. ALS is strongly associated with mortality, with higher ALS linked to an increased risk of mortality across both continuous and categorical analyses. Models that incorporate ALS with LF parameters demonstrated superior predictive performance and greater robustness, underscoring the added value of including LF in the models.
- 6 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessIntegration of lung function in allostatic load scoring and its impact on mortality prediction
Allostatic load refers to the physiological "wear and tear" that results from adaptation to stressors over the lifespan. In this study, we integrated lung function (LF) parameters into the calculation of the allostatic load score (ALS) to evaluate changes in its performance for predicting all-cause mortality. Data from 8,775 participants (aged 25–82 years; 52% female) who participated in the first wave of the Austrian LEAD cohort were used. “ALS without LF” was calculated using 12 parameters, including cardiovascular, metabolic, body composition, and bone mineral density measures. Z-scores of forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were integrated with the aforementioned parameters for the calculation of “ALS with LF”. Participants scored 1 point for each at-risk marker and 1 point for medication use for hypertension, diabetes, and dyslipidaemia. The total points constituted the ALS. Participants were followed-up for death for an average of 7.7 years. The association of ALS, with and without LF, with mortality was investigated using Cox proportional hazards models. ALS increased with age and was higher in males compared to females across all age categories. ALS (as a continuous variable) with LF [hazard ratio (HR): 1.19 (95% confidence interval (CI) 1.14–1.24)] and without LF [HR: 1.16 (95% CI 1.11–1.21)] showed a significant association with mortality in sex- and age-adjusted models. The adjusted models incorporating ALS as a categorical variable showed that individuals with high ALS, with [HR: 2.44 (95% CI 1.41–4.20)] and without [HR: 2.47 (95% CI 1.46–4.80)] LF parameters, had a higher risk of mortality compared to those in the low ALS group. Cox models incorporating “ALS with LF” parameters exhibited higher concordance index and R2 values, along with a lower Akaike’s information criterion indicating superior predictive power compared to models that included “ALS without LF”. ALS is strongly associated with mortality, with higher ALS linked to an increased risk of mortality across both continuous and categorical analyses. Models that incorporate ALS with LF parameters demonstrated superior predictive performance and greater robustness, underscoring the added value of including LF in the models.
- Open Access
- 5 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-13
Reference equations for pulse wave velocity, augmentation index, amplitude of forward and backward wave in a European general adult population
Pulsatile hemodynamics have been shown to be independent predictors of cardiovascular events. The aim of the current study was to describe four pulsatile hemodynamic markers in a large, well-established, population-based cohort and to provide reference equations for sex- and age-based standardization of these measurements. 6828 adult participants from the Austrian LEAD (Lung, hEart, sociAl, boDy) cohort study, who were free from overt cardiovascular disease, non-diabetic based on blood test results, and had no history of pharmacological treatment for hypertension, dyslipidemia, and diabetes, comprised the “reference population”. Carotid-femoral pulse wave velocity (cfPWV), augmentation index (AIx), amplitude of forward wave (Pf), and backward wave (Pb) were described in different age categories for both sexes. Sex-specific reference equations for cfPWV, AIx, Pf, and Pb with age as the predictive variable were created using the Lambda-Mu-Sigma (LMS) method. All four parameters increased with age. CfPWV and Pf were higher in males than females, especially in young and middle-age groups (P < 0.001). AIx was higher in females than males in all age categories (P < 0.001). Pb was also higher in females than males in age groups older than 40 years (P < 0.01). Reference equations for the skewness (Lambda), median (Mu), and coefficient of variation (Sigma) values were determined, enabling the calculation of sex- and age-standardized values (z-scores) for each individual’s pulsatile hemodynamic measurement, and an online application was developed. Reference equations derived from a large population-based dataset constitute a suitable tool for the standardization of pulsatile hemodynamics and for the accurate interpretation of vascular aging.
- 5 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-13
Open AccessReference equations for pulse wave velocity, augmentation index, amplitude of forward and backward wave in a European general adult population
Pulsatile hemodynamics have been shown to be independent predictors of cardiovascular events. The aim of the current study was to describe four pulsatile hemodynamic markers in a large, well-established, population-based cohort and to provide reference equations for sex- and age-based standardization of these measurements. 6828 adult participants from the Austrian LEAD (Lung, hEart, sociAl, boDy) cohort study, who were free from overt cardiovascular disease, non-diabetic based on blood test results, and had no history of pharmacological treatment for hypertension, dyslipidemia, and diabetes, comprised the “reference population”. Carotid-femoral pulse wave velocity (cfPWV), augmentation index (AIx), amplitude of forward wave (Pf), and backward wave (Pb) were described in different age categories for both sexes. Sex-specific reference equations for cfPWV, AIx, Pf, and Pb with age as the predictive variable were created using the Lambda-Mu-Sigma (LMS) method. All four parameters increased with age. CfPWV and Pf were higher in males than females, especially in young and middle-age groups (P < 0.001). AIx was higher in females than males in all age categories (P < 0.001). Pb was also higher in females than males in age groups older than 40 years (P < 0.01). Reference equations for the skewness (Lambda), median (Mu), and coefficient of variation (Sigma) values were determined, enabling the calculation of sex- and age-standardized values (z-scores) for each individual’s pulsatile hemodynamic measurement, and an online application was developed. Reference equations derived from a large population-based dataset constitute a suitable tool for the standardization of pulsatile hemodynamics and for the accurate interpretation of vascular aging.
- Open Access
- 11 October 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (20) , 4660
COPD Diagnosis: Time for Disruption
Articulating a satisfactory definition of a disease is surprisingly difficult. Despite the alarming individual, societal and economic burden of chronic obstructive pulmonary disease (COPD), diagnosis is still largely based on a physiologically dominated disease conception, with spirometrically determined airflow limitation as a cardinal feature of the disease. The diagnostic inaccuracy and insensitivity of this physiological disease definition is reviewed considering scientific developments of imaging of the respiratory system in particular. Disease must be approached as a fluid concept in response to new scientific and medical discoveries, but labelling as well as mislabelling someone as diseased, will have enormous individual, social and financial implications. Nosology of COPD urgently needs to dynamically integrate more sensitive diagnostic procedures to detect the breadth of abnormalities early in the disease process. Integration of broader information for the identification of abnormalities in the respiratory system is a cornerstone for research models of underlying pathomechanisms to create a breakthrough in research.
- 11 October 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (20) , 4660
Open AccessCOPD Diagnosis: Time for Disruption
Articulating a satisfactory definition of a disease is surprisingly difficult. Despite the alarming individual, societal and economic burden of chronic obstructive pulmonary disease (COPD), diagnosis is still largely based on a physiologically dominated disease conception, with spirometrically determined airflow limitation as a cardinal feature of the disease. The diagnostic inaccuracy and insensitivity of this physiological disease definition is reviewed considering scientific developments of imaging of the respiratory system in particular. Disease must be approached as a fluid concept in response to new scientific and medical discoveries, but labelling as well as mislabelling someone as diseased, will have enormous individual, social and financial implications. Nosology of COPD urgently needs to dynamically integrate more sensitive diagnostic procedures to detect the breadth of abnormalities early in the disease process. Integration of broader information for the identification of abnormalities in the respiratory system is a cornerstone for research models of underlying pathomechanisms to create a breakthrough in research.